Press release
Neurodegenerative Disorder Therapeutics Market 2023: By Indication Type, Drug Type, Global Analysis And Forecast To 2032
Neurodegenerative Disorder Therapeutics Market
As per the neurodegenerative disorder therapeutics market report by The Business Research Company, increased prevalence of neurodegenerative among the global population contributes to the growth of the neurodegenerative disorder therapeutics market. The increase in the geriatric population attributes to the increased prevalence of neurodegenerative disorders.
The global neurodegenerative disorder therapeutics market grew from $15.86 billion in 2022 to $17.14 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The neurodegenerative disorder therapeutics market is expected to grow from $23.65 billion in 2027 at a CAGR of 8.4%.
Read More On The Neurodegenerative Disorder Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report
Major competitors in the neurodegenerative disorder therapeutics market include Biogen, Pfizer, Novartis, Sanofi, Teva Pharmaceutical, UCB, Hoffmann- La Roche Ltd., ACADIA Pharmaceuticals Inc., Lundeck A/S, Boehringer Ingeiheim International GmbH, Merck Serono, Orion Pharma Ltd., Mitsubishi Tanabe Pharma America, Allergan, GlaxoSmith Kline PLC., AbbVie, Eli lilly, Celgene, Neuro- Hitech Inc., Bayer Schering Pharma AG, Amarin Corporation, AstraZeneca, Alector, Yumanity Therapeutics, Yangtze River Pharmaceutical Group, Chongqing Zein Pharmaceutical and Eisai
The neurodegenerative disorder therapeutics market is segmented -
By Indication Type: Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Other Indication Types
By Drug Type: N- methyl- D- aspartate Receptor, Selective Serotonin Reuptake Inhibitor, Dopamine Inhibitors, Other Drug Types
By Distribution: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the neurodegenerative disorder therapeutics market.
Check Out Buying Options For The Neurodegenerative Disorder Therapeutics Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2818
Neurodegenerative disorder therapeutics refer to a medication or gene therapy to treat patients with neurodegenerative disorders therapeutically by directly rectifying pathogenic pathways, through neuroprotection, neurorestoration, and symptom control.
The Table Of Content For The Neurodegenerative disorder therapeutics market Include:
1. Executive Summary
2. Neurodegenerative Disorder Therapeutics Market Characteristics
3. Neurodegenerative Disorder Therapeutics Market Trends And Strategies
4. Neurodegenerative Disorder Therapeutics Market - Macro Economic Scenario
5. Neurodegenerative Disorder Therapeutics Market Size And Growth
......
27. Neurodegenerative Disorder Therapeutics Market Competitive Landscape And Company Profiles
28. Neurodegenerative Disorder Therapeutics Pipeline Analysis
29. Key Mergers And Acquisitions In The Neurodegenerative Disorder Therapeutics Market
30. Neurodegenerative Disorder Therapeutics Market Future Outlook and Potential Analysis
31. Appendix
The "Global Neurodegenerative disorder therapeutics market Report 2023" from The Business Research Company is a comprehensive report that covers every facet of a market covering over 60 geographies and over 2500 market segments. The regional and country breakdowns section analyzes the market in each geography and the market size by region and country. Furthermore, it assesses the market's historical and projected growth and identifies significant trends and strategies that companies can leverage for business expansion.
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neurodegenerative Disorder Therapeutics Market 2023: By Indication Type, Drug Type, Global Analysis And Forecast To 2032 here
News-ID: 2875052 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Neurodegenerative
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Neurodegenerative Disorder Therapeutics Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market size for therapeutics for neurodegenerative disorders has seen robust growth. The growth is expected to rise from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
"The Neurodegenerative Disorder Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Neurodegenerative Disorder Therapeutics Market Size and Its Estimated Growth Rate?
The neurodegenerative disorder therapeutics market has shown strong growth, expected to increase from $18.53 billion in 2024 to $20.04 billion…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder…
Growing Prevalence Of Neurodegenerative Disorders Fuels Neurodegenerative Disord …
How Is the Neurodegenerative Disorder Therapeutics Market Projected to Grow, and What Is Its Market Size?
Seen significant expansion in recent years, the market size for neurodegenerative disorder therapeutics is predicted to climb from $18.53 billion in 2024 to $20.04 billion in 2025, maintaining a compound annual growth rate (CAGR) of 8.1%. The prior growth phase can be credited to factors such as an aging society, an upsurge in neurodegenerative disorder…
Novel Antibodies in Neurodegenerative Disease Treatment
Neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, represent some of the most challenging medical conditions due to their progressive nature and lack of effective treatments. Novel antibodies are emerging as promising therapeutic agents, offering targeted and innovative approaches to slow disease progression and improve patient outcomes. This article explores the role of novel antibodies in the treatment of neurodegenerative diseases, highlighting their mechanisms of action and therapeutic potential.
Download…
